CANAAN X L.P.

Director at Protagonist Therapeutics, Inc · on record since Aug 16, 2016
10% owner at Protagonist Therapeutics, Inc · on record since Aug 16, 2016
Director at Iterum Therapeutics plc · on record since May 30, 2018
10% owner at Iterum Therapeutics plc · on record since May 30, 2018
10% owner at IDEAYA Biosciences, Inc. · on record since May 28, 2019
10% owner at NextCure, Inc. · on record since May 13, 2019
10% owner at ASTRALIS LTD · on record since Jul 19, 2021

Insider trading activity of CANAAN X L.P.

Transactions on record: 25; since Mar 22, 2018

Open-market buys: 3; $11.3M

Open-market sells: 3; $814.5K

Companies traded: 4; last filing Jan 23, 2020

Figures computed from official regulatory filings — .

Companies where CANAAN X L.P. has traded

Iterum Therapeutics plc8 tx · $6.6M · Jan 23, 2020
IDEAYA Biosciences, Inc.5 tx · $4M · May 28, 2019
NextCure, Inc.9 tx · $750K · May 13, 2019
Protagonist Therapeutics, Inc3 tx · $814.5K · Mar 22, 2018

Track record of CANAAN X L.P.

Insufficient history for a statistical track record (fewer than 5 open-market buys).

Transaction history of CANAAN X L.P.

Co-insiders of CANAAN X L.P.

This page republishes public regulatory disclosures.

Company	Filed	Type	Qty	Price	Value · USD	Signals	Src
Iterum Therapeutics plcListing unverified	Jan 23, 2020	AwardD (derivative)	0	2,000,000.00 USD	n/a (Converted to USD in the nightly refresh)		SEC
IDEAYA Biosciences, Inc.Listing on record	May 28, 2019	Other	1,658,164	—	n/a (No price was disclosed in the filing)		SEC
IDEAYA Biosciences, Inc.Listing on record	May 28, 2019	OtherD (derivative)	-602,549	—	n/a (No price was disclosed in the filing)		SEC
IDEAYA Biosciences, Inc.Listing on record	May 28, 2019	Buy	400,000	10.00 USD	$4M	conv 41Cluster	SEC
IDEAYA Biosciences, Inc.Listing on record	May 28, 2019	Other	602,549	—	n/a (No price was disclosed in the filing)		SEC
IDEAYA Biosciences, Inc.Listing on record	May 28, 2019	OtherD (derivative)	-1,658,164	—	n/a (No price was disclosed in the filing)		SEC
NextCure, Inc.Listing on record	May 13, 2019	OtherD (derivative)	-3,582,000	—	n/a (No price was disclosed in the filing)		SEC
NextCure, Inc.Listing on record	May 13, 2019	Other	445,866	—	n/a (No price was disclosed in the filing)		SEC
NextCure, Inc.Listing on record	May 13, 2019	OtherD (derivative)	-5,970,000	—	n/a (No price was disclosed in the filing)		SEC
NextCure, Inc.Listing on record	May 13, 2019	Buy	50,000	15.00 USD	$750K	conv 42Cluster	SEC
NextCure, Inc.Listing on record	May 13, 2019	OtherD (derivative)	-5,861,455	—	n/a (No price was disclosed in the filing)		SEC
NextCure, Inc.Listing on record	May 13, 2019	Other	285,867	—	n/a (No price was disclosed in the filing)		SEC
NextCure, Inc.Listing on record	May 13, 2019	Other	743,110	—	n/a (No price was disclosed in the filing)		SEC
NextCure, Inc.Listing on record	May 13, 2019	Other	729,599	—	n/a (No price was disclosed in the filing)		SEC
NextCure, Inc.Listing on record	May 13, 2019	OtherD (derivative)	-2,296,605	—	n/a (No price was disclosed in the filing)		SEC
Iterum Therapeutics plcListing unverified	May 30, 2018	Buy	506,656	13.00 USD	$6.6M	conv 61ClusterFirst in 12mo	SEC
Iterum Therapeutics plcListing unverified	May 30, 2018	Other	275,446	—	n/a (No price was disclosed in the filing)		SEC
Iterum Therapeutics plcListing unverified	May 30, 2018	OtherD (derivative)	-229,660	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Iterum Therapeutics plcListing unverified	May 30, 2018	Other	229,660	—	n/a (No price was disclosed in the filing)		SEC
Iterum Therapeutics plcListing unverified	May 30, 2018	Other	721,408	—	n/a (No price was disclosed in the filing)		SEC
Iterum Therapeutics plcListing unverified	May 30, 2018	OtherD (derivative)	-275,446	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Iterum Therapeutics plcListing unverified	May 30, 2018	OtherD (derivative)	-721,408	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Protagonist Therapeutics, IncListing on record	Mar 22, 2018	Sell	-17,060	20.61 USD	$351.6K		SEC
Protagonist Therapeutics, IncListing on record	Mar 22, 2018	Sell	-4,759	20.62 USD	$98.1K		SEC
Protagonist Therapeutics, IncListing on record	Mar 22, 2018	Sell	-17,699	20.61 USD	$364.8K		SEC

Company	Filed	Type	Qty	Price	Value · USD	Signals	Src
Iterum Therapeutics plcListing unverified	Jan 23, 2020	AwardD (derivative)	0	2,000,000.00 USD	n/a (Converted to USD in the nightly refresh)		SEC
IDEAYA Biosciences, Inc.Listing on record	May 28, 2019	Other	1,658,164	—	n/a (No price was disclosed in the filing)		SEC
IDEAYA Biosciences, Inc.Listing on record	May 28, 2019	OtherD (derivative)	-602,549	—	n/a (No price was disclosed in the filing)		SEC
IDEAYA Biosciences, Inc.Listing on record	May 28, 2019	Buy	400,000	10.00 USD	$4M	conv 41Cluster	SEC
IDEAYA Biosciences, Inc.Listing on record	May 28, 2019	Other	602,549	—	n/a (No price was disclosed in the filing)		SEC
IDEAYA Biosciences, Inc.Listing on record	May 28, 2019	OtherD (derivative)	-1,658,164	—	n/a (No price was disclosed in the filing)		SEC
NextCure, Inc.Listing on record	May 13, 2019	OtherD (derivative)	-3,582,000	—	n/a (No price was disclosed in the filing)		SEC
NextCure, Inc.Listing on record	May 13, 2019	Other	445,866	—	n/a (No price was disclosed in the filing)		SEC
NextCure, Inc.Listing on record	May 13, 2019	OtherD (derivative)	-5,970,000	—	n/a (No price was disclosed in the filing)		SEC
NextCure, Inc.Listing on record	May 13, 2019	Buy	50,000	15.00 USD	$750K	conv 42Cluster	SEC
NextCure, Inc.Listing on record	May 13, 2019	OtherD (derivative)	-5,861,455	—	n/a (No price was disclosed in the filing)		SEC
NextCure, Inc.Listing on record	May 13, 2019	Other	285,867	—	n/a (No price was disclosed in the filing)		SEC
NextCure, Inc.Listing on record	May 13, 2019	Other	743,110	—	n/a (No price was disclosed in the filing)		SEC
NextCure, Inc.Listing on record	May 13, 2019	Other	729,599	—	n/a (No price was disclosed in the filing)		SEC
NextCure, Inc.Listing on record	May 13, 2019	OtherD (derivative)	-2,296,605	—	n/a (No price was disclosed in the filing)		SEC
Iterum Therapeutics plcListing unverified	May 30, 2018	Buy	506,656	13.00 USD	$6.6M	conv 61ClusterFirst in 12mo	SEC
Iterum Therapeutics plcListing unverified	May 30, 2018	Other	275,446	—	n/a (No price was disclosed in the filing)		SEC
Iterum Therapeutics plcListing unverified	May 30, 2018	OtherD (derivative)	-229,660	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Iterum Therapeutics plcListing unverified	May 30, 2018	Other	229,660	—	n/a (No price was disclosed in the filing)		SEC
Iterum Therapeutics plcListing unverified	May 30, 2018	Other	721,408	—	n/a (No price was disclosed in the filing)		SEC
Iterum Therapeutics plcListing unverified	May 30, 2018	OtherD (derivative)	-275,446	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Iterum Therapeutics plcListing unverified	May 30, 2018	OtherD (derivative)	-721,408	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Protagonist Therapeutics, IncListing on record	Mar 22, 2018	Sell	-17,060	20.61 USD	$351.6K		SEC
Protagonist Therapeutics, IncListing on record	Mar 22, 2018	Sell	-4,759	20.62 USD	$98.1K		SEC
Protagonist Therapeutics, IncListing on record	Mar 22, 2018	Sell	-17,699	20.61 USD	$364.8K		SEC